Suppr超能文献

经皮胆囊造瘘术治疗急性胆囊炎高危患者。

Percutaneous cholecystostomy for high-risk patients with acute cholecystitis.

作者信息

Welschbillig-Meunier K, Pessaux P, Lebigot J, Lermite E, Aube Ch, Brehant O, Hamy A, Arnaud J P

机构信息

Department of Visceral Surgery, Chu Angers, 4 rue Larrey, 49033, Angers Cedex, France.

出版信息

Surg Endosc. 2005 Sep;19(9):1256-9. doi: 10.1007/s00464-004-2248-6. Epub 2005 Jul 14.

Abstract

BACKGROUND

Cholecystectomy remains the best treatment for acute cholecystitis but may cause high morbidity and mortality in critically ill or elderly patients.

METHODS

From October 1995 to March 2004, percutaneous cholecystostomy was performed in 65 patients with acute cholecystitis. The mean age was 78 years (range, 45-95). All patients were American Society of Anesthesiologists (ASA) class III (n = 51) or ASA IV (n = 14).

RESULTS

Percutaneous cholecystostomy was technically successful in 63 patients (97%) with no attributable mortality or major complications. In two patients, bile drainage was inefficient, requiring emergency laparoscopic cholecystectomy. One patient developed necrotic cholecystitis and died. The 30-day mortality rate was 13.8% (n = 9); eight patients died of respiratory or cardiac complications related to comorbidities. Mean drainage time was 18 days (range, 9-60). Postoperative length of hospital stay was 15 days (range, 7-30). Early and delayed cholecystitis occurred in six and five patients, respectively. During follow-up (mean, 20.4 months), five patients died of their underlying medical condition at 5, 6, 8, 12, and 14 months, respectively. In this study, delayed elective cholecystectomy was performed in 10 patients (15.3%).

CONCLUSIONS

Percutaneous cholecystostomy is a valuable and effective procedure without mortality and with a low morbidity. Whenever possible, percutaneous cholecystostomy should be followed by laparoscopic cholecystectomy.

摘要

背景

胆囊切除术仍是急性胆囊炎的最佳治疗方法,但在重症或老年患者中可能导致高发病率和死亡率。

方法

1995年10月至2004年3月,对65例急性胆囊炎患者实施了经皮胆囊造瘘术。平均年龄为78岁(范围45 - 95岁)。所有患者均为美国麻醉医师协会(ASA)Ⅲ级(n = 51)或ASAⅣ级(n = 14)。

结果

63例患者(97%)经皮胆囊造瘘术在技术上成功,无相关死亡或严重并发症。2例患者胆汁引流不畅,需要急诊腹腔镜胆囊切除术。1例患者发生坏死性胆囊炎并死亡。30天死亡率为13.8%(n = 9);8例患者死于与合并症相关的呼吸或心脏并发症。平均引流时间为18天(范围9 - 60天)。术后住院时间为15天(范围7 - 30天)。分别有6例和5例患者发生早期和延迟性胆囊炎。在随访期间(平均20.4个月),5例患者分别在5、6、8、12和14个月死于基础疾病。本研究中,10例患者(15.3%)接受了延迟选择性胆囊切除术。

结论

经皮胆囊造瘘术是一种有价值且有效的手术,无死亡率且发病率低。只要有可能,经皮胆囊造瘘术后应行腹腔镜胆囊切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验